4-Aminoquinoline

4-Aminoquinoline
Structural formula of 4-aminoquinoline
Space-filling model of the 4-aminoquinoline molecule
Names
Preferred IUPAC name
Quinolin-4-amine
Identifiers
CAS Number
  • 578-68-7 ☒N
3D model (JSmol)
  • Interactive image
ChEMBL
  • ChEMBL58146 checkY
ChemSpider
  • 61751 checkY
ECHA InfoCard 100.167.771 Edit this at Wikidata
PubChem CID
  • 68476
UNII
  • GTE5P5L97N checkY
CompTox Dashboard (EPA)
  • DTXSID70206491 Edit this at Wikidata
InChI
  • InChI=1S/C9H8N2/c10-8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H2,10,11) checkY
    Key: FQYRLEXKXQRZDH-UHFFFAOYSA-N checkY
  • n1ccc(c2ccccc12)N
Properties
Chemical formula
C9H8N2
Molar mass 144.177 g·mol−1
Appearance Powder to crystalline, White/Yellow/Orange
Melting point 151.0 to 155.0 °C
Hazards
Occupational safety and health (OHS/OSH):
Main hazards
Causes skin and serious eye irritation
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references
Chemical compound

4-Aminoquinoline is a form of aminoquinoline with the amino group at the 4-position of the quinoline. The compound has been used as a precursor for the synthesis of its derivatives.[1]

A variety of derivatives of 4-aminoquinoline are antimalarial agents useful in treating erythrocytic plasmodial infections.[2] Examples include amodiaquine, chloroquine, and hydroxychloroquine.[3] Other uses for the derivatives are: anti-asthmatic, antibacterial, anti-fungal, anti-malarial, antiviral and anti-inflammatory agents. [1]

A patent application for 4-aminoquinoline compounds was filed in 2002 and published in 2005.[4]

See also

References

  1. ^ a b Al-Ahmary KM, Alenezi MS, Habeeb MM (2016-08-01). "Synthesis, spectroscopic and DFT theoretical studies on the hydrogen bonded charge transfer complex of 4-aminoquinoline with chloranilic acid". Journal of Molecular Liquids. 220: 166–182. doi:10.1016/j.molliq.2016.04.074. ISSN 0167-7322.
  2. ^ Bosak A, Opsenica DM, Šinko G, Zlatar M, Kovarik Z (2019-08-01). "Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase". Chemico-Biological Interactions. 308: 101–109. Bibcode:2019CBI...308..101B. doi:10.1016/j.cbi.2019.05.024. ISSN 0009-2797. PMID 31100281. S2CID 157067252.
  3. ^ Bray PG, Hawley SR, Ward SA (1996). "4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake". Mol. Pharmacol. 50 (6): 1551–8. PMID 8967977.
  4. ^ DeVita R, Chang L (13 January 2005). "4-Aminoquinoline Compounds" (PDF). United States Patent Application Publication.

External links

  • Bourne SA, De Villiers K, Egan TJ (2006). "Three 4-aminoquinolines of antimalarial interest". Acta Crystallogr C. 62 (Pt 2): o53–7. Bibcode:2006AcCrC..62O..53B. doi:10.1107/S0108270105041235. PMID 16456284.
  • "4-Aminoquinoline 578-68-7 | TCI America". www.tcichemicals.com. Retrieved 2020-03-06.
  • v
  • t
  • e
Alveo-
late
Apicom-
plexa
Conoidasida/
(Coccidiostats)
Cryptosporidiosis
Isosporiasis
Toxoplasmosis
Aconoidasida
Malaria
Individual
agents
Hemozoin
inhibitors
Aminoquinolines
4-Methanolquinolines
Other
Antifolates
DHFR inhibitors
Sulfonamides
Co-formulation
Sesquiterpene
lactones
Other
Combi-
nations
Fixed-dose (co-formulated) ACTs
Other combinations
(not co-formulated)
  • artesunate/mefloquine
  • artesunate/SP
  • quinine/clindamycin
  • quinine/doxycycline
  • quinine/tetracycline
Babesiosis
Cilio-
phora
Stramen-
opile
Stub icon

This article about a heterocyclic compound is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e